INTRODUCTION
Hepatitis C virus (HCV) infection is one the main causes of chronic liver disease worldwide. The number of chronically infected persons worldwide is estimated to be about 160 million, but most are unaware of their infection [1] . Approximately 700,000 persons die each year from HCV related complications, which include cirrhosis, hepatoceullar carcinoma (HCC) and liver failure [2] . The most recent epidemiological survey done in Egypt revealed that 10% of the population had HCV antibody and 7% had positive HCV-RNA [3] .
Number of studies have demonstrated a strong association between HCV infection and insulin resistance (IR), providing a possible link between this infection and diabetes mellitus [4] . Prediabetes mellitus is defined as a state of abnormal glucose homeostasis in which deficiency or resistance to insulin is the hallmark. Prediabetes mellitus precedes the development of overt type 2 diabetes mellitus (T2DM). It is associated with increased mortality and morbidity, and thus fits well with the criteria of a disease condition [5] . The gold standard for the assessment of IR is the euglycemic hyperinsulinemic clamp technique. Another more practicable and also well-accepted method of measuring systemic IR is the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). It is calculated by the following formula: fasting glucose (mmol/L) × fasting insulin (μU/L)/22.5 [6] . In previous reports, HOMA less than 2 has been considered 'completely' normal and higher than 2 as prediabetic state [7] . The progression of prediabetes to T2DM has been examined in a number of populations with varying results. In general, epidemiological studies indicate that approximately 25% of individuals progress to T2DM in 5 years, whereas about 50% remain prediabetic and about 25% revert to normal [8] . The aim of this study was to assess the frequency of prediabetes assessed by (HOMA-IR) in patients with chronic HCV infection.
SUBJECTS AND METHODS

Subjects :
This study was conducted on 80 subjects attending or admitted to the Department of Hepatology, Gastroenterology and Infectious Diseases and outpatient clinic at Benha University hospital during the period from May 2016 to April 2017 after approval of Benha University ethical committee. They were classified into 3 groups. Group I: included thirty patients with chronic HCV with no evidence of cirrhosis, group II: included thirty patients with HCV related cirrhosis and group ІIІ: twenty apparently healthy volunteers of matched age, sex and BMI were included as control group. Exclusion criteria included clinical evidence of diabetes mellitus, family history of T2DM, non HCV related liver disease, e.g (HBV, alcohol abuse, hepatic schistosomiasis, autoimmune hepatitis, hemochromatosis, Wilson disease, hepatocellular carcinoma, any endocrinal disorder, diabetogenic drugs e.g. (steroids), severe systemic diseases (cardiac, respiratory or renal diseases), obese patients (BMI>30) & waist hip ratio (for men above 0.9 and for women above 0.85).
Materials :
All the patients and controls were subjected to full history taking, complete clinical examination including (1) ) were used to compare differences between more than two groups regarding parametric and nonparametric data respectively, followed by posthoc test using the Bonferroni method to detect differences in pairs. The person correlation coefficient (r) and the Spearman Correlation coefficient (rho; ρ) were used to test for the correlation between estimated parameters as appropriate. Table 1 showed that there was no significant difference between the studied groups regarding age, sex, BMI and waist Hip ratio (P =1.00, 0.43, 0.46, 0.14, respectively). The mean value of fasting blood glucose was significantly higher in both of group I (4.9±0.5) and group II (5±0.5) than controls (4.7±0.3) mmol/L with P value (0.04). The mean value of fasting insulin level was significantly higher in both of group I (12.71±7.89) and group II (12.86±7.71) than controls (mean=4.12±1.48) with P value (<0.001). The mean value of HOMA-IR was significantly higher in both of group I (2.94±1.81) and group II (2.9±1.81) than controls (0.28-1.41) with P value (<0.001). Table 3 shows that pre diabetes was significantly higher in both group I (63.33%) and group II (63.33%) than controls (0.00%) (P<0.001). Child-Pugh score classification of group II showed that 15 patients (50%) were Child A, 6 patients (20%) were Child B and 9 patients (30%) were Child C. Table 4 showed that there was no significant difference between Child score classification of group II regarding fasting glucose level, fasting insulin and HOMA-IR (P = 0.5, 0.36 and 0.41, respectively). . IR has a major role in development of T2DM and it is the best predictor for the development of T2DM, and it assumes an essential part in development of T2DM [12] . HCV advances the progression of IR directly by affecting insulin signaling pathway at the cellular level. In addition, IR may play a role in the progression of the liver disease. In euglycemic individuals the estimation of HOMA-IR level helps to quantify IR [13] . Diabetes can adversely affect the course of CHC [14] . In this study we aimed to assess the frequency of prediabetes assessed by (HOMA-IR) in patients with chronic HCV infection.
RESULTS
In this study, statistical analysis revealed significant difference between the studied groups as regard fasting blood glucose; it was higher in both of group I and group II than controls, and there was no significant difference between group I and group II. In addition, in this study statistical analysis revealed significant difference between the studied groups as regard fasting insulin level; it was higher in both of group I and group II than controls and there was no significant difference between group I and group II. In addition, statistical analysis revealed significant difference between the studied groups as regard HOMA-IR; it was higher in both of group I and group II than controls and there was no statistically significant difference between group I and group II. 
CONCLUSION
This study showed that the frequency of prediabetes among non-diabetic chronic HCV patients was 63.33%. In addition, prediabetes in chronic HCV patients was not connected with the severity of liver disease and insulin resistance is a direct viral feature. Also this study concluded that HCV patients should be assessed for IR and prediabetes in their routine evaluation, to avoid the double burden of DM and HCV.
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